ARTICLE | Company News
Emergent BioSolutions, Centers for Disease Control and Prevention infectious news
August 22, 2016 7:00 AM UTC
Emergent said the CDC exercised an option under a 2012 deal for Emergent to supply Vaccinia Immune Globulin (VIGIV) for the U.S. strategic national stockpile. The option is valued at $11.6 million ov...